Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Diabetes

Free Subscription Articles published in Ophthalmology Retrieve available abstracts of 29 articles: HTML format

Single Articles

December 2024
1. BAI WH, Bai YC, Wei JC
   Re: Muayad et al.: Comparative effects of GLP-1 receptor agonists and metformin on glaucoma risk in patients with type 2 diabetes (Ophthalmology. 2024 Aug 23:S0161-6420(24)00515-3).
   Ophthalmology. 2024 Dec 21:S0161-6420(24)00743.
   PubMed    
   
   
   November 2024
2. CHUANG SH, Chang CH
   Re: Muayad et al.: Comparative effects of GLP-1 receptor agonists and metformin on glaucoma risk in type 2 diabetes patients (Ophthalmology. Aug 23 2024;doi:10.1016/j.ophtha.2024.08.023).
   Ophthalmology. 2024 Nov 28:S0161-6420(24)00682.
   PubMed    
   
   
   October 2024
3. KHODEIRY MM, Perez AM, Chang TC
   Pediatric Diabetic Cataract Variations: Intumescence and Volume Loss.
   Ophthalmology. 2024 Oct 18:S0161-6420(24)00568.
   PubMed    
   
   
   August 2024
4. LUM F
   Re: Chauhan et al.: Association of primary open-angle glaucoma with diabetic retinopathy among patients with type 1 and type 2 diabetes. a large global database study. (Ophthalmology. 2024;131:827-835).
   Ophthalmology. 2024 Aug 29:S0161-6420(24)00460.
   PubMed    
   
   
   
5. MUAYAD J, Loya A, Hussain ZS, Chauhan MZ, et al
   Comparative Effects of GLP-1 Receptor Agonists and Metformin on Glaucoma Risk in Type 2 Diabetes Patients.
   Ophthalmology. 2024 Aug 23:S0161-6420(24)00515.
   PubMed     Abstract available
   
   
   
6. CHAUHAN MZ, Elhusseiny AM, Uwaydat SH
   Reply to: Re: Chauhan et al.: Association of Primary Open-Angel Glaucoma with Diabetic Retinopathy among Patients with Type 1 and Type 2 Diabetes.
   Ophthalmology. 2024 Aug 3:S0161-6420(24)00461.
   PubMed    
   
   
   July 2024
7. BAI WH, Bai YC, Wei JC
   Re: Chauhan et al.: Association of primary open-angle glaucoma with diabetic retinopathy among patients with type 1 and type 2 diabetes: a large global database study (Ophthalmology. 2024;131:827-835).
   Ophthalmology. 2024 Jul 25:S0161-6420(24)00389.
   PubMed    
   
   
   
8. YANG S, Liu R, Xin Z, Zhu Z, et al
   Plasma metabolomics identifies key metabolites and improves prediction of diabetic retinopathy: development and validation across multi-national cohorts.
   Ophthalmology. 2024 Jul 5:S0161-6420(24)00415.
   PubMed     Abstract available
   
   
   
9. JONAS JB, Bikbov MM, Kazakbaeva GM, Wang YX, et al
   Positive and Negative Associations of Myopia with Ocular Diseases in Population-Based Studies.
   Ophthalmology. 2024 Jul 4:S0161-6420(24)00414.
   PubMed     Abstract available
   
   
   June 2024
10. ZARBIN M, Tabano D, Ahmed A, Amador M, et al
    Efficacy of Faricimab vs Aflibercept in Diabetic Macular Edema in the 20/50 or Worse Vision Subgroup in Phase 3 YOSEMITE/RHINE Trials.
    Ophthalmology. 2024 Jun 7:S0161-6420(24)00320.
    PubMed     Abstract available
    
    
    April 2024
11. WENG CY, Maguire MG, Flaxel CJ, Jain N, et al
    Effectiveness of Conventional Digital Fundus Photography-Based Teleretinal Screening for Diabetic Retinopathy and Diabetic Macular Edema: A Report by the American Academy of Ophthalmology.
    Ophthalmology. 2024 Apr 11:S0161-6420(24)00156.
    PubMed     Abstract available
    
    
    March 2024
12. NIAZI S, Gnesin F, Thein AS, Andreasen JR, et al
    Association between Glucagon-like Peptide-1 Receptor Agonists and the Risk of Glaucoma in Individuals with Type 2 Diabetes.
    Ophthalmology. 2024 Mar 8:S0161-6420(24)00171.
    PubMed     Abstract available
    
    
    February 2024
13. JHAVERI CD, Liu D, Maguire MG, Glassman AR, et al
    Risk Factors for Meeting Criteria for Switching from Bevacizumab to Aflibercept When Treating Eyes with Diabetic Macular Edema and Visual Acuity <20/40.
    Ophthalmology. 2024 Feb 7:S0161-6420(24)00098.
    PubMed     Abstract available
    
    
    
14. WU Y, Egan C, Olvera-Barrios A, Scheppke L, et al
    Developing a Continuous Severity Scale for Macular Telangiectasia Type 2 Using Deep Learning and Implications for Disease Grading.
    Ophthalmology. 2024;131:219-226.
    PubMed     Abstract available
    
    
    January 2024
15. SAMMONS EL, Buck G, Bowman LJ, Stevens WM, et al
    ASCEND-Eye: Effects of Aspirin on Diabetic Retinopathy.
    Ophthalmology. 2024 Jan 16:S0161-6420(24)00056.
    PubMed     Abstract available
    
    
    
16. CHAUHAN MZ, Elhusseiny AM, Kishor KS, Sanvicente CT, et al
    Association of Primary Open-Angle Glaucoma with Diabetic Retinopathy Among Patients with Type 1 and Type 2 Diabetes: A Large Global Database Study.
    Ophthalmology. 2024 Jan 10:S0161-6420(24)00052.
    PubMed     Abstract available
    
    
    December 2023
17. WONG TY, Haskova Z, Asik K, Baumal CR, et al
    Faricimab Treat-and-Extend for Diabetic Macular Edema: 2-Year Results from the Randomized Phase 3 YOSEMITE and RHINE Trials.
    Ophthalmology. 2023 Dec 27:S0161-6420(23)00933.
    PubMed     Abstract available
    
    
    
18. SAMMONS EL, Buck G, Bowman LJ, Stevens WM, et al
    ASCEND-Eye: Effects of Omega-3 Fatty Acids on Diabetic Retinopathy.
    Ophthalmology. 2023 Dec 3:S0161-6420(23)00870.
    PubMed     Abstract available
    
    
    
19. EHRLICH JR, Andes LJ, Eisenberg A, Saaddine J, et al
    Trends in the Diagnosed Prevalence and Incidence of Major Eye Diseases in Medicare Part B Fee-for-Service Beneficiaries 68 Years of Age or Older.
    Ophthalmology. 2023;130:1240-1247.
    PubMed     Abstract available
    
    
    June 2023
20. TACCHERI C, Jordan J, Tran D, Wang J, et al
    The impact of social determinants of health on eye care utilization in a national sample of people with diabetes.
    Ophthalmology. 2023 Jun 15:S0161-6420(23)00425.
    PubMed     Abstract available
    
    
    March 2023
21. REGILLO C, Berger B, Brooks L, Clark WL, et al
    Archway Phase 3 Trial of the Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration 2-Year Results.
    Ophthalmology. 2023 Mar 2:S0161-6420(23)00135.
    PubMed     Abstract available
    
    
    February 2023
22. SHAKARCHI AF, Soliman MK, Yang YC, Sallam AB, et al
    Risk of Pseudophakic Cystoid Macular Edema in Fellow-Eye Cataract Surgeries: A Multicenter Database Study.
    Ophthalmology. 2023 Feb 3:S0161-6420(23)00063.
    PubMed     Abstract available
    
    
    December 2022
23. BAKER CW, Josic K, Maguire MG, Jampol LM, et al
    Comparison of Snellen Visual Acuity Measurements in Retinal Clinical Practice to eETDRS Protocol Visual Acuity Assessment.
    Ophthalmology. 2022 Dec 12:S0161-6420(22)00976.
    PubMed     Abstract available
    
    
    August 2022
24. LOIS N, Campbell C, Waugh N, Azuara-Blanco A, et al
    DIAbetic Macular Oedema aNd Diode Subthreshold micropulse laser (DIAMONDS): A randomized double-masked non-inferiority clinical trial.
    Ophthalmology. 2022 Aug 13. pii: S0161-6420(22)00631.
    PubMed     Abstract available
    
    
    
25. CHIA MA, Taylor JR, Stuart KV, Khawaja AP, et al
    Prevalence of diabetic retinopathy in Indigenous and non-Indigenous Australians: a systematic review and meta-analysis.
    Ophthalmology. 2022 Aug 2. pii: S0161-6420(22)00566.
    PubMed     Abstract available
    
    
    May 2022
26. MELLES RB, Marmor MF
    Rapid Macular Thinning is an Early Indicator of Hydroxychloroquine Retinal Toxicity.
    Ophthalmology. 2022 May 11. pii: S0161-6420(22)00335.
    PubMed     Abstract available
    
    
    January 2022
27. SINGER MA, Sheth V, Mansour SE, Coughlin B, et al
    Three-year safety and efficacy of the 0.19-mg fluocinolone acetonide intravitreal implant for diabetic macular edema: the PALADIN study.
    Ophthalmology. 2022 Jan 18. pii: S0161-6420(22)00067.
    PubMed     Abstract available
    
    
    October 2021
28. GONZALEZ VH, Wang PW, Ruiz CQ
    Panretinal Photocoagulation for Diabetic Retinopathy in the RIDE and RISE Trials: Not "1 and Done".
    Ophthalmology. 2021;128:1448-1457.
    PubMed     Abstract available
    
    
    June 2021
29. LENG T, Gallivan MD, Kras A, Lum F, et al
    Ophthalmology and COVID-19: The Impact of the Pandemic on Patient Care and Outcomes-an IRIS Registry Study.
    Ophthalmology. 2021 Jun 15. pii: S0161-6420(21)00455.
    PubMed    
    
    

Thank you for your interest in scientific medicine.

AMEDEO Diabetes is free of charge.